Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

(2012) M. Sugimoto et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy of Twice-Daily Rabeprazole for Reflux Esophagitis Patients Refractory to Standard Once-Daily Administration of PPI: The Japan-Based TWICE Study

(2012) Yoshikazu Kinoshita et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Impact of Acid Inhibition on Esophageal Mucosal Injury Induced by Low-Dose Aspirin

(2011) Mitsushige Sugimoto et al.   DIGESTION

Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers

(2009) Masafumi Nishino et al.   DIGESTIVE DISEASES AND SCIENCES

Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects

(2009) Chise Kodaira et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

(2008) Katsuyoshi Sugimoto et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY